 3. to assess the effect of Memantine in clinical course new relapses, relapse rate, patients free of relapses, disability EDSS, MSFC, MSSS and MRI parameters active lesions: new T2 lesions, change in T2 lesion load, new gadolinium enhancing lesions and global and regional atrophy in the response to Memantine. MRI study is optional. 